CCR2 and neoplasm: For example, blocking CCR2 or CCL2 (CCR2 ligand) expression in tumor cells is particularly effective in alleviating the tumor progression and overcoming the resistance to anti-PD-1 therapy after incomplete radiofrequency ablation (138).